Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (231-240 of 471) with videos related to

Pageof 48
Sort By:
Blood Cancer Journal|April 12, 2022
Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantationAbdullah S Al Saleh, Mohammad S Ebraheem, M Hasib Sidiqi, et al.
Bone Marrow Transplantation|April 3, 2022
Success of the autologous stem cell boost after autologous graft failure in multiple myeloma and AL amyloidosisJoselle Cook, Wilson I Gonsalves, Morie A Gertz, et al.
British Journal of Haematology|May 10, 2026
Predictors of renal response in AL amyloidosis following anti-plasma cell therapy: The impact of baseline serum free light chain levels and light chain isotypeMatthew J Rees, Binoy Yohannan, Susan Geyer, et al.
Blood Cancer Journal|November 17, 2018
Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myelomaPraful Ravi, Shaji K Kumar, Lindsey Roeker, et al.
Mayo Clinic Proceedings|May 6, 2015
Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin depositsGauri Bhutani, Samih H Nasr, Samar M Said, et al.
Blood|November 9, 2011
Immunoglobulin D amyloidosis: a distinct entityMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Blood Cancer Journal|November 10, 2018
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myelomaM Hasib Sidiqi, Mohammed A Aljama, Irbaz Bin Riaz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2013
Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantationAbhishek Singla, William J Hogan, Stephen M Ansell, et al.
Blood|June 25, 2014
Trends in survival of patients with primary plasma cell leukemia: a population-based analysisWilson I Gonsalves, S Vincent Rajkumar, Ronald S Go, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2024
Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel TherapiesCharalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
Pageof 48

Showing results (231-240 of 471) with videos related to

Sort By:
Pageof 48
Blood Cancer Journal|April 12, 2022
Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantationAbdullah S Al Saleh, Mohammad S Ebraheem, M Hasib Sidiqi, et al.
Bone Marrow Transplantation|April 3, 2022
Success of the autologous stem cell boost after autologous graft failure in multiple myeloma and AL amyloidosisJoselle Cook, Wilson I Gonsalves, Morie A Gertz, et al.
British Journal of Haematology|May 10, 2026
Predictors of renal response in AL amyloidosis following anti-plasma cell therapy: The impact of baseline serum free light chain levels and light chain isotypeMatthew J Rees, Binoy Yohannan, Susan Geyer, et al.
Blood Cancer Journal|November 17, 2018
Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myelomaPraful Ravi, Shaji K Kumar, Lindsey Roeker, et al.
Mayo Clinic Proceedings|May 6, 2015
Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin depositsGauri Bhutani, Samih H Nasr, Samar M Said, et al.
Blood|November 9, 2011
Immunoglobulin D amyloidosis: a distinct entityMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
Blood Cancer Journal|November 10, 2018
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myelomaM Hasib Sidiqi, Mohammed A Aljama, Irbaz Bin Riaz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2013
Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantationAbhishek Singla, William J Hogan, Stephen M Ansell, et al.
Blood|June 25, 2014
Trends in survival of patients with primary plasma cell leukemia: a population-based analysisWilson I Gonsalves, S Vincent Rajkumar, Ronald S Go, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2024
Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel TherapiesCharalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
Pageof 48